Harold M Burkhart, MD
Disclosures: Nothing to disclose - 10/24/2019
PHS 398/2590 (Rev. 06/09), Biographical Sketch Format Page

Program Director/Principal Investigator (Last, First, Middle):             

BIOGRAPHICAL SKETCH

Provide the following information for the Senior/key personnel and other significant contributors in the order listed on Form Page 2.
Follow this format for each person. DO NOT EXCEED FOUR PAGES.

 

NAME

Harold M. Burkhart

POSITION TITLE

Professor of Surgery

Director of Pediatric Cardiothoracic Surgery

University of Oklahoma Health Sciences Center

eRA COMMONS USER NAME (credential, e.g., agency login)

 

EDUCATION/TRAINING  (Begin with baccalaureate or other initial professional education, such as nursing, include postdoctoral training and residency training if applicable.)

INSTITUTION AND LOCATION

DEGREE

(if applicable)

MM/YY

FIELD OF STUDY

University of Tennessee

BA

5/1988

Zoology

East Tennessee State University

MD

6/1992

Medicine

University of Tennessee

 

6/1993

Surgery, Intern

Indiana University

Mayo Clinic College of Medicine

 

University of Toronto

 

 

6/1999

6/2002

 

6/2003

Surgery, Resident

Cardiothoracic Surgery, Fellow

Pediatric Cardiothoracic Surgery, Fellow

 

 

 

 

PHS 398/2590 (Rev. 06/09)              Page                   Biographical Sketch Format Page


Program Director/Principal Investigator (Last, First, Middle):             

 

NOTE: The Biographical Sketch may not exceed four pages. Follow the formats and instructions below.

A.              Personal Statement

Briefly describe why your experience and qualifications make you particularly well-suited for your role (e.g., PD/PI, mentor, participating faculty) in the project that is the subject of the application.  Within this section you may, if you choose, briefly describe factors such as family care responsibilities, illness, disability, and active duty military service that may have affected your scientific advancement or productivity.

B.              Positions and Honors

Assistant Professor of Surgery, Director of Pediatric Cardiothoracic Surgery, University of Iowa, 2003-07

 

Associate Professor of Surgery, Mayo Clinic College of Medicine, Consultant Cardiothoracic Surgery, 2007-12

 

Professor of Surgery, Mayo Clinic College of Medicine, Consultant Cardiothoracic Surgery, 2012-14

 

Professor of Surgery, Director of Pediatric Cardiothoracic Surgery, University of Oklahoma, 2014-

 

C.              Selected Peer-reviewed Publications

1.              Crow SS, Oliver WC Jr, Kiefer JA, Snyder MR, Dearani JA, Li Z, Burkhart HM. Dexamethasone levels predict cortisol response after infant cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2013 Nov 07. PMID:24210831. DOI:10.1016/j.jtcvs.2013.09.023.

2.              Wittwer ED, Lynch JJ, Oliver WC Jr, Dearani JA, Burkhart HM, Mauermann WJ. The incidence of vasoplegia in adult patients with right-sided congenital heart defects undergoing cardiac surgery and the correlation with serum vasopressin concentrations. J Thorac Cardiovasc Surg. 2013 Nov 23. PMID:24280713. DOI:10.1016/j.jtcvs.2013.10.037.

3.              Suri RM, Burkhart HM. Optimizing outcomes of robotic mitral valve repair for all prolapse anatomy: the Suri-Burkhart technique. Ann Cardiothoracic Surg. 2013 Nov;2(6): 841-845. PMID:24349993

 

4.              Ugur M, Suri RM, Daly RC, Dearani JA, Park SJ, Joyce LD, Burkhart HM, Greason KL, Schaff HV. Comparison of early hemodynamic performance of 3 aortic valve bioprostheses. J Thorac Cardiovasc Surg. 2014 Jan 15. [Epub ahead of print] PMID:24530199 DOI :10.1016/j.jtcvs.2013.12.051.

 

5.              Stulak JM, Suri RM, Burkhart HM, Daly RC, Dearani JA, Greason KL, Joyce LD, Park SJ, Schaff HV. Surgical ablation for atrial fibrillation for two decades: Are the results of new techniques equivalent to the Cox maze III procedure? J Thorac Cardiovasc Surg. 2014 May;147(5) 181478-87. Epub 2014 Jan 18: PMID: 24560517 DOI: 10.1016/j.jtcvs.2013.10.084.

 

6.              Robinson JA, Driscoll DJ, O'Leary PW, Burkhart HM, Dearani JA, Daly RC, Edwards BS, Dahl SH, Johnson JN. Cardiac and multiorgan transplantation for end-stage congenital heart disease. Mayo Clin Proc. 2014 Apr; 89(4):478-83. PMID:24684872 DOI: 10.1016/j.mayocp.2013.11.019.

 

7.              Said SM, Burkhart HM. When repair is not feasible: prosthesis selection in children and adults with congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2014;17(1):22-9. DOI: 10.1053/j.pcsu.2014.01.002. PMID: 24725713

 

8.              Said SM, Burkhart HM, Dearani JA, Connolly HM, Schaff HV. Ascending-to-descending aortic bypass: a simple solution to a complex problem. Ann Thorac Surg. 2014 Apr 12. [Epub ahead of print] PMID: 24725830DOI: 10.1016/j.athoracsur.2014.02.030.

 

9.              Said SM, Burkhart HM, Schaff HV, Cetta F, Driscoll DJ, Li Z, Oliver WC Jr, Ammash NM, Dearani JA. Fontan conversion: Identifying the high-risk patient. Ann Thorac Surg. 2014 Apr 29. [Epub ahead of print] PMID: 24786860 DOI: 10.1016/j.athoracsur.2014.01.083.

 

10.              Sharma V, Deo SV, Huebner M, Dearani JA, Burkhart HM. In search of the ideal pulmonary blood source for the Norwood procedure: A meta-analysis and systematic review. Ann Thorac Surg. 2014 Apr 30. [Epub ahead of print] PMID: 24793687DOI: 10.1016/j.athoracsur.2014.02.078.

 

D.              Research Support

 

Program Director / Principal Investigator             

Improving Patient Safety by Simulator Based Training in Cardiac Surgery in: Improved Patient Safety by Simulator Based Training in Cardiac Surgery. Funded by Agency for Healthcare Research and Quality. (R18 HS 20451)             

05/2011 - 04/2014

 

Principal Investigator             

Stem Cell Delivery Device. Funded by Mayo Clinic Ventures Novel Technologies Award.             

02/2013 - 02/2014

 

Co-Investigator             

The Minnesota Congenital Heart Network. Funded by Minnesota Partnership for Biotechnology and Medical Genomics. (H904600538)             

01/2009 - 09/2011

 

Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome. (Mayo Clinic Grant)

 

* 1-Phase I study of autologous cord blood cell therapy during surgical stage II palliation of Hypoplastic Left Heart Syndrome (HLHS) 

             

* 2-Bioengineered cardiac tissue for Hypoplastic Left Hear Syndrome analysis

             

* 3-Preclinical safety/toxicology studies for porcine autologous umbilical cord blood (UCB)-derived mononuclear cells transplanted into the right ventricle muscle

PHS 398/2590 (Rev. 06/09)              Page   1                Biographical Sketch Format Page